HIV/AIDS and other infectious diseases among correctional inmates: Transmission, burden, and an appropriate response

American Journal of Public Health

Volumn 96, Issue 6, 2006, Pages 974-978

  Hammett, Theodore M ^a  

^a ABT ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG DEPENDENCE TREATMENT; HEALTH CARE QUALITY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NONHUMAN; PATIENT COUNSELING; PATIENT EDUCATION; PREVALENCE; PRISON; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMANS; INTERINSTITUTIONAL RELATIONS; MANDATORY TESTING; PREVALENCE; PRISONERS; PRISONS; PUBLIC HEALTH ADMINISTRATION; RISK-TAKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33744725298     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.066993     Document Type: Review

References (73)

1. Krebs CP. High-risk HIV transmission behavior in prison and the prison subculture. Prison J. 2002;82:19-49.
2. Mahon N. New York inmates' HIV risk behaviors: the implications for prevention policy and programs. Am J Public Health. 1996;86:1211-1215.
3. Calzavara L, Myers T, Millson M, et al. Understanding HIV-Related Risk Behavior in Prison: The Inmates' Perspective. Toronto, Ont: University of Toronto; 1997.
4. Swartz JA, Lurigio AJ, Weiner DA. Correlates of HIV-risk behaviors among prison inmates: implications for tailored AIDS prevention programming. Prison J. 2004;84:486-504.
5. Gyarmathy VA, Neaigus A, Szamado S. HIV risk behavior history of prison inmates in Hungary. AIDS Educ Prev. 2003;15:561-569.
6. Lines R, Jurgens R, Betteridge G, et al. Prison Needle Exchange: Lessons From a Comprehensive Review of International Evidence and Experience. Montreal, Quebec: Canadian HIV/AIDS Legal Network; 2004.
7. Thaisri H, Lerwitworapong J, Vongsheree S, et al. HIV infection and risk factors among Bangkok prisoners: a prospective cohort study. BMC Infect Dis. 2003;3:25.
8. Davies R. Prison's second death row. Lancet. 2004;364:317-318.
9. Liptak A. Ex-inmate's suit offers view into sexual slavery in prisons. New York Times. October 16, 2004:A1.
10. Human Rights Watch. No Escape: Male Rape in US Prisons. 2001. Available at: http://www.hrw.org/reports/2001/prison/report.html. Accessed October 21, 2004.
11. Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr. 2002;29:86-94.
12. Buavirat A, Page-Shaffer K, van Griensven GJP, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok: case-control study. BMJ. 2003;326:308.
13. Butler TG, Dolan KA, Person MJ, McGuiness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997;166:127-130.
14. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004;132: 409-415.
15. Long J, Allwright S, Barry J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ. 2001;323:1-6.
16. Dolan K. Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug Alcohol Dependence. 1998;50:197-202.
17. Gore SM, Bird AG, Cameron SO, Hutchinson SJ, Burns SM, Goldberg DJ. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. Q J Med. 1999;92:25-32.
18. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218-1223.
19. Champion JK, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol. 2004;159: 514-519.
20. Horsburgh LR, Jarvis JQ, McCarther T, et al. Seroconversion to HIV in prison inmates. Am J Public Health. 1990;80:209-210.
21. Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a state-wide prison system. AIDS. 1988;2: 363-367.
22. Castro KG, Shansky R, Scardino V, Narkunas J, Coe J, Hammett T. HIV transmission in correctional facilities. Poster presented at: VII International Conference on AIDS; June 16-21, 1991; Florence, Italy.
23. Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;310:289-292.
24. Dolan KA, Wodak A. HIV transmission in a prison system in an Australian state. Med J Aust. 1999;171: 14-17.
25. O'Sullivan BG, Levy MH, Dolan KA, et al. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. Med J Aust. 2003;178: 546-549.
26. Haber PS, Parsons SJ, Harper SE, White PA, Rawlinson WD, Lloyd AR. Transmission of hepatitis C within Australian prisons. Med J Aust. 1999;171: 31-33.
27. Centers for Disease Control and Prevention. Hepatitis B outbreak in a state correctional facility, 2000. MMWR Morb Mortal Wkly Rep. 2001; 50:529-532.
28. Wolfe MI, Xu F, Patel P, et al. An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. Am J Public health. 2001;91:1220-1225.
29. Van Hoeven KH, Rooney WC, Joseph SC. Evidence of gonococcal transmission within a correctional system. Am J Public Health. 1990;80: 1505-1506.
30. Mutter RC, Crimes RM, Labarthe D. Evidence of intraprison spread of HIV infection. Arch Int Med. 1994;154: 793-795.
31. Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. AIDS Educ Prev. 2002; 14(suppl B):53-64.
32. Diaz RS, Kallas EG, Castelo A, Rawal BD, Busch MP. Use of a new, less-sensitive enzyme immunoassay, testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. AIDS. 1999;13:1417-1418.
33. National Commission on Correctional Health Care. The Health Status of Soon-to-Be-Released Inmates: A Report to Congres. Chicago, Ill: National Commission on Correctional Health Care; 2002.
34. Maruschak LM. HIV in Prisons, 2000. Washington, DC: Bureau of Justice Statistics; 2002. Report no. NCJ 196023, October 2002.
35. Baillargeon J, Black SA, Leach CT, et al. The infectious disease profile of Texas prison inmates. Prev Med. 2004; 38:607-612.
36. Brown K. Managing STIs in jails. Infectious Diseases in Corrections Report. 2005;8:1-4. Available at: http//www.idcronline.org/archives/april05/ article.html. Accessed May 20, 2005.
37. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92:189-194.
38. Hammett TM. AIDS in Correctional Facilities: Issues and Options. 3rd ed. Washington, DC: National Institute of Justice; 1988.
39. Maruschak LM. HIV in Prisons, 2001. Washington, DC: Bureau of Justice Statistics; 2004. Report no. NCJ 202293.
40. Desai AA, Latta ET, Spaulding A, Rich JD, Flanigan TP. The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev. 2002; 14(suppl B):45-52.
41. Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health. 2003;93:759-763.
42. World Health Organization. WHO Guidelines on HIV Infection and AIDS in Prisons. Geneva, Switzerland: World Health Organization; 1993
43. Weinstein C, Greenspan J. Mandatory HIV testing in prisons. Am J Public Health. 2003;93:1617.
44. Altice FL, Marinovich A, Khoshnood K, Blankenship KM, Springer SA, Selwyn PA. Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J Urban Health. 2005;92:312-326.
45. Grinstead O, Seal DW, Wolitski R, et al. HIV and STD testing in prisons: perspectives of in-prison service providers. AIDS Educ Prev. 2003;15: 547-560.
46. Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD: Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003;138:187-190.
47. Hammett TM. Hepatitis C treatment in correctional facilities. Ann Intern Med. 2003;138:235-236.
48. Stephenson BL, Wohl DA, Golin CE, Tien H-C, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84-88.
49. Altice FL, Mostashiri F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28: 47-58.
50. Von Zielbauer P. As health care in jails goes private, 10 days can be a death sentence. New York Times. February 27, 2005:1.
51. Hammett TM, Harmon P, Maruschak LM. 1996-1997 Update: HIV/AIDS, STDs, and TB in Correctional Facilities. Washington, DC: National Institute of Justice, Centers for Disease Control and Prevention, and Bureau of Justice Statistics; 1999. Report no. NCJ 176344.
52. Staples B. Fighting the AIDS epidemic by issuing condoms in the prisons. New York Times. September 7, 2004:A22.
53. Dolan K, Lowe D, Shearer J. Evaluation of the condom distribution program in New South Wales prisons, Australia. J Law Med Ethics. 2004;32: 124-128.
54. HIV/AIDS in Prisons: Background Materials. Montreal, Quebec: McGill Centre for Law, Medicine, and Ethics; 1994.
55. May JP, Williams EL. Acceptability of condom availability in a US jail. AIDS Educ Preu. 2002;14(suppl B): 85-91.
56. Jurgens R, Lines R, Kerr T, et al. Prison needle exchange: a review of international evidence and experience. Poster abstract presented at XV International AIDS Conference; Bangkok, Thailand; July 11-16, 2004.
57. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development Addiction. 2003;98:153-158.
58. Centers for Disease Control and Prevention. Hepatitis B vaccination of inmates in correctional facilities-Texas, 2000-2002. MMWR Morb Mortal Wkly Rep. 2004;53:681-683.
59. Pisu M, Meltzer MI, Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine. 2002;21: 312-321.
60. Butzin CA, Martin SS, Inciardi JA. Evaluating component effects of prison-based treatment continuum. J Subst Abuse Treatment. 2002;22:63-69.
61. Pelissier B, Gaes G, Rhodes W, et al. TRIAD Drug Treatment Evaluation Project. Washington, DC: Federal Bureau of Prisons; 2000.
62. National Center on Addiction and Substance Abuse at Columbia University (CASA). Behind Bars: Substance Abuse and America's Prison Population. New York, NY: CASA; 1998.
63. Stover H, Hennebel LC, Casselman J. Substitution Treatment in European Prisons. London, UK: European Network of Drug Services in Prison and Cranstoun Drug Services; 2004.
64. Dolan KA, Shearer J, McDonald M, Mattick RP, Hall W, Wodak AD. A randomized controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Dependence. 2003;72: 59-65.
65. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001;68: 14-20.
66. Fiscella K, Moore A, Engerman J. Jail management of arrestees/inmates enrolled in community methadone maintenance programs. J Urban Health. 2004;81:645-654.
67. Travis J. But They All Come Back: Facing the Challenges of Prisoner Reentry. Washington, DC: Urban Institute Press; 2005.
68. Roberts C, Kennedy S, Hammett TM. Linkages between in-prison and community-based health services. J Correctional Health Care. 2004;10: 333-368.
69. Conklin TL, Lincoln T, Flanigan TP. A public health model connecting correctional health care with communities. Am J Public Health. 1998;88: 1249-1250.
70. Seal DW, Margolis AD, Sosman J, Kacanek D, Binson D, and the Project START Study Group. HIV and STD risk behavior among 18- to 25-year-old men released from US prisons: provider perspectives. AIDS Behav. 2003;7: 131-141.
71. Hammett TM. Public Health/Corrections Collaborations: Prevention and treatment of HIV/AIDS, STDs, and TB. Research in Brief. Washington, DC: National Institute of Justice, 1998.
72. World Health Organization. Status paper on Prisons, Drugs and Harm Reduction. Copenhagen, Denmark: WHO Regional Office for Europe; 2005.
73. Prison health: a threat or an opportunity? Lancet. 2005;366:1.